Ascendis Pharma A/S
Edit

Ascendis Pharma A/S

https://ascendispharma.com/
Last activity: 14.03.2024
Categories: MedtechITHumanGrowthFashionDrugBodyActiveProductTechnology
Endocrine-focused biopharmaceutical company developing long-acting human growth hormone for the treatment of pediatric growth hormone deficiency
Mentions
86
Location: Denmark, Capital Region of Denmark, Gentofte Municipality
Total raised: $168M

Investors 8

Funding Rounds 2

DateSeriesAmountInvestors
29.01.2015IPO$108M-
01.12.2014Series D$60M-

Mentions in press and media 86

DateTitleDescriptionSource
14.03.2024AstraZeneca Acquisition Brings Drug to Fill a Rare Disease G...AstraZeneca is bolstering its rare disease pipeline with a deal to buy Amolyt Pharma, a biotech comp...medcitynew...
03.03.2024'There's an enormous catch-up trade': These 5 small-cap stoc...Markets 'There's an enormous catch-up trade': These 5 small-cap stocks are destined to soar, accordi...businessin...
31.01.2024Ascendis Pharma to Report Full Year 2023 Financial Results a...COPENHAGEN, Denmark, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today anno...einpresswi...
31.01.2024Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® N...COPENHAGEN, Denmark, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today anno...einpresswi...
16.11.2023Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objectiv...SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutic...en.prnasia...
05.06.2023Ascendis Pharma Opens Compassionate Use Program for TransCon.../EIN News/ -- – Compassionate use enables treating physicians in Germany to request access to invest...einpresswi...
31.05.2023Ascendis Pharma Oncology Program Update Highlights Latest Cl.../EIN News/ -- – TransCon IL-2 β/γ in Phase 1 clinical trial showed monotherapy clinical activity in ...einpresswi...
25.05.2023Ascendis Pharma to Host Oncology Program Update on May 31/EIN News/ -- COPENHAGEN, Denmark, May 25, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASN...einpresswi...
13.05.2023Ascendis Pharma Showcases Commitment to Rare Endocrine Disea.../EIN News/ -- COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASN...einpresswi...
03.05.2023Ascendis Pharma to Participate in the BofA Securities 2023 H.../EIN News/ -- COPENHAGEN, Denmark, May 03, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASN...einpresswi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In